Fate Therapeutics, Inc. (FATE)

1.56 +0.05 (+3.31%) USD  |  NASDAQ  |  Feb 24, 10:24
More

Fate Therapeutics Properties (Per Share)

Properties (Per Share) Chart

View Properties (Per Share) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Properties (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Properties (Per Share) Range, Past 5 Years

View Properties (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Properties (Per Share) Benchmarks

View Properties (Per Share) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vertex Pharmaceuticals, Inc. --
Ardelyx, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --